Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Moodys
McKinsey
McKesson
Dow
AstraZeneca
Medtronic
UBS
Teva
Healthtrust

Generated: January 18, 2018

DrugPatentWatch Database Preview

METHOCARBAMOL AND ASPIRIN Drug Profile

« Back to Dashboard

Which patents cover Methocarbamol And Aspirin, and when can generic versions of Methocarbamol And Aspirin launch?

Methocarbamol And Aspirin is a drug marketed by Ivax Sub Teva Pharms, Mcneil, Par Pharm, and Stevens J. and is included in four NDAs.

The generic ingredient in METHOCARBAMOL AND ASPIRIN is aspirin; methocarbamol. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; methocarbamol profile page.
Summary for METHOCARBAMOL AND ASPIRIN
Drug patent expirations by year for METHOCARBAMOL AND ASPIRIN

US Patents and Regulatory Information for METHOCARBAMOL AND ASPIRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms METHOCARBAMOL AND ASPIRIN aspirin; methocarbamol TABLET;ORAL 087211-001 Dec 22, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Stevens J METHOCARBAMOL AND ASPIRIN aspirin; methocarbamol TABLET;ORAL 081145-001 Jan 31, 1995 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mcneil METHOCARBAMOL AND ASPIRIN aspirin; methocarbamol TABLET;ORAL 089193-001 Feb 12, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Pharm METHOCARBAMOL AND ASPIRIN aspirin; methocarbamol TABLET;ORAL 089657-001 Nov 4, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Johnson and Johnson
Mallinckrodt
Federal Trade Commission
Merck
Queensland Health
Chinese Patent Office
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot